From: Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
Predictor | ‘Cure’ (functional definition) Total n = 33 | ‘Fail’ (functional definition) Total n = 19 | p-value (functional definition) | ‘Cure’ (microbiological definition) Total n = 20 | ‘Fail’ (microbiological definition) Total n = 19 | p-value (microbiological definition) |
---|---|---|---|---|---|---|
Fosfomycin resistant in vitro | 1/33 | 1/19 | 0.21 | 0/20 | 1/19 | 0.99 |
Klebsiella pneumoniae | 2/33 | 5/19 | 0.04 | 2/20 | 5/19 | 0.13 |
Comorbidity (any, including transplant/urethral catheter) | 21/33 | 14/19 | 0.22 | 15/20 | 14/19 | 0.47 |
Median eGFR, ml/min (IQR) | 64 (41–86) | 90 (29–90) | 0.19 | 64 (37–87) | 90 (29–90) | 0.20 |